Mayne Pharma Group Ltd banner

Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 2.53 AUD 5.86% Market Closed
Market Cap: AU$205.6m

Profitability Summary

Mayne Pharma Group Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Mayne Pharma Group Ltd

Margins Comparison
Mayne Pharma Group Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
AU
Mayne Pharma Group Ltd
ASX:MYX
205.6m AUD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
952.4B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
592.2B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
284.1B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
243.9B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
234.8B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
298.8B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.6B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.8B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Mayne Pharma Group Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
AU
Mayne Pharma Group Ltd
ASX:MYX
205.6m AUD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
952.4B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
592.2B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
284.1B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
243.9B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
234.8B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
298.8B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.6B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.8B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Mayne Pharma Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett